This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MercadoLibre Soars 33% in a Year: Should Investors Buy the Stock Now?
by Zacks Equity Research
MELI expands investments in Mexico and improves risk-mitigation strategies, presenting a compelling entry point for investors in 2025.
MercadoLibre (MELI) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
In the closing of the recent trading day, MercadoLibre (MELI) stood at $2,067.57, denoting a +0.08% change from the preceding trading day.
3 Reasons Growth Investors Will Love MercadoLibre (MELI)
by Zacks Equity Research
MercadoLibre (MELI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are Retail-Wholesale Stocks Lagging Herbalife Ltd (HLF) This Year?
by Zacks Equity Research
Here is how Herbalife Ltd (HLF) and MercadoLibre (MELI) have performed compared to their sector so far this year.
Is It Worth Investing in MercadoLibre (MELI) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for MercadoLibre (MELI) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
MercadoLibre (MELI) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
MercadoLibre (MELI) concluded the recent trading session at $2,021.37, signifying a +1.59% move from its prior day's close.
MercadoLibre (MELI) Stock Moves -0.75%: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, MercadoLibre (MELI) stood at $1,989.70, denoting a -0.75% change from the preceding trading day.
Why MercadoLibre (MELI) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
MercadoLibre (MELI) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
In the closing of the recent trading day, MercadoLibre (MELI) stood at $2,009.34, denoting a -1.76% change from the preceding trading day.
Here is Why Growth Investors Should Buy MercadoLibre (MELI) Now
by Zacks Equity Research
MercadoLibre (MELI) could produce exceptional returns because of its solid growth attributes.
Earnings Estimates Rising for MercadoLibre (MELI): Will It Gain?
by Zacks Equity Research
MercadoLibre (MELI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
MercadoLibre (MELI) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
MercadoLibre (MELI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Are Retail-Wholesale Stocks Lagging MercadoLibre (MELI) This Year?
by Zacks Equity Research
Here is how MercadoLibre (MELI) and Walgreens Boots Alliance (WBA) have performed compared to their sector so far this year.
Is MercadoLibre (MELI) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for MercadoLibre (MELI) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
If You Invested $1000 in MercadoLibre a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Why MercadoLibre (MELI) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Sprouts Farmers Market and e.l.f. Beauty have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Sprouts Farmers Market and e.l.f. Beauty have been highlighted as Zacks Bull and Bear of the Day.
Add MercadoLibre Stock to Your Portfolio After Solid Q4 Earnings?
by Vasundhara Sawalka
MELI's Q4 strength impresses, but premium valuation gives pause. Investors can hold the stock or find better entry points in 2025 as competition intensifies.
Here's Why MercadoLibre (MELI) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Zacks Analyst Blog Highlights Alibaba, Pfizer, MercadoLibre and SIFCO
by Zacks Equity Research
Alibaba, Pfizer, MercadoLibre and SIFCO are included in this Analyst Blog.
Top Research Reports for Alibaba, Pfizer & MercadoLibre
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), Pfizer Inc. (PFE) and MercadoLibre, Inc. (MELI), as well as a micro-cap stock SIFCO Industries, Inc. (SIF).
Company News for Feb 24, 2025
by Zacks Equity Research
Companies in The News Are: ABR,ED,MELI,ITGR
MercadoLibre's Q4 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
MELI's fourth-quarter 2024 results benefit from a surge in commerce and fintech revenues backed by strong growth in Brazil and Mexico.
MercadoLibre (MELI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for MercadoLibre (MELI) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
MercadoLibre (MELI) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
MercadoLibre (MELI) delivered earnings and revenue surprises of 73.69% and 3.71%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?